Editorial & Opinion
أعرض في EDS

Availability of drugs for severe COVID-19 in sub-Saharan Africa.

التفاصيل البيبلوغرافية
العنوان: Availability of drugs for severe COVID-19 in sub-Saharan Africa.
المؤلفون: Njonnou SRS; Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.; The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19*), Dschang, Cameroon., Ouankou CN; Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.; The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19*), Dschang, Cameroon.; Department of Internal Medicine and Specialties, Yaoundé University Teaching Hospital, Yaoundé, Cameroon., Lekpa FK; Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.; The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19*), Dschang, Cameroon.; Department of Internal Medicine, Douala General Hospital, Douala, Cameroon., Balti EV; Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.; The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19*), Dschang, Cameroon.; Diabetes Research Center and Department of Internal Medicine, Universiteit Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium., Choukem SP; Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.; The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19*), Dschang, Cameroon.; Health and Human Development (2HD) Research Network, Douala, Cameroon.
المصدر: The Pan African medical journal [Pan Afr Med J] 2020 May 26; Vol. 35 (Suppl 2), pp. 48. Date of Electronic Publication: 2020 May 26 (Print Publication: 2020).
نوع المنشور: Letter
اللغة: English
بيانات الدورية: Publisher: African Field Epidemiology Network Country of Publication: Uganda NLM ID: 101517926 Publication Model: eCollection Cited Medium: Internet ISSN: 1937-8688 (Electronic) NLM ISO Abbreviation: Pan Afr Med J Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Kampala, Uganda : African Field Epidemiology Network
مواضيع طبية MeSH: COVID-19 Drug Treatment*, Receptors, Interleukin-6/*immunology, Africa South of the Sahara ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/pharmacology ; COVID-19/physiopathology ; Humans ; Severity of Illness Index
مستخلص: Competing Interests: The author declares no competing interests.
References: Front Pharmacol. 2018 Sep 20;9:1070. (PMID: 30294275)
Autoimmun Rev. 2020 Jul;19(7):102568. (PMID: 32376398)
N Engl J Med. 2020 Sep 3;383(10):994. (PMID: 32649078)
BMJ. 2020 May 14;369:m1844. (PMID: 32409486)
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. (PMID: 32350134)
JAMA. 2020 May 12;323(18):1824-1836. (PMID: 32282022)
Int J Antimicrob Agents. 2020 Jul;56(1):105949. (PMID: 32205204)
Health Aff (Millwood). 2015 Mar;34(3):519-27. (PMID: 25715657)
N Engl J Med. 2020 May 7;382(19):1787-1799. (PMID: 32187464)
J Clin Invest. 2020 Jun 1;130(6):2757-2765. (PMID: 32254064)
فهرسة مساهمة: Keywords: COVID-19; drug availability; effective treatment; severe
المشرفين على المادة: 0 (Antibodies, Monoclonal, Humanized)
0 (Receptors, Interleukin-6)
I031V2H011 (tocilizumab)
تواريخ الأحداث: Date Created: 20210224 Date Completed: 20210309 Latest Revision: 20240806
رمز التحديث: 20240806
مُعرف محوري في PubMed: PMC7875718
DOI: 10.11604/pamj.supp.2020.35.2.23698
PMID: 33623573
قاعدة البيانات: MEDLINE
الوصف
تدمد:1937-8688
DOI:10.11604/pamj.supp.2020.35.2.23698